U.S. flag An official website of the United States government
Topic Paragraphs
Call-To-Action Video

Call-To-Action Title
FDA Commissioner Dr. Robert M. Califf and FDA's Center for Biologics Evaluation and Research Director Dr. Peter Marks will be taking questions

Join us for a virtual press conference to discuss the FDA's draft recommendations to eliminate time-based deferrals for certain populations at increased risk of HIV and instead to assess blood donor eligibility using gender-inclusive, individual risk-based questions to reduce the risk of transfusion-transmitted HIV.

Virtual Press Conference: Blood Donation Guidance – 1/27/2023
Back to Top